Work

NICE recommends olaparib for advanced breast cancer in final draft guidance

Year: 2025

Type: article

Source: Pharmaceutical journal/The pharmaceutical journal

DOI: 10.1211/pj.2025.1.343160

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4406305062

FWCI:

Cites:

Cited by:

Related to: 10